| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.94B | 45.52B | 45.86B | 40.97B | 51.12B | 53.49B |
| Gross Profit | 10.07B | 9.24B | 9.14B | 7.49B | 9.31B | 10.13B |
| EBITDA | 1.77B | 1.45B | 1.22B | 21.88M | 784.93M | 1.14B |
| Net Income | 1.11B | 673.08M | 648.47M | -245.66M | 326.31M | 509.31M |
Balance Sheet | ||||||
| Total Assets | 49.13B | 50.55B | 46.41B | 49.91B | 46.89B | 52.61B |
| Cash, Cash Equivalents and Short-Term Investments | 8.18B | 10.43B | 11.64B | 13.25B | 9.04B | 8.96B |
| Total Debt | 18.59B | 18.41B | 16.90B | 21.74B | 19.67B | 23.40B |
| Total Liabilities | 34.09B | 35.23B | 31.50B | 35.40B | 31.84B | 35.69B |
| Stockholders Equity | 15.04B | 15.32B | 14.91B | 14.52B | 15.05B | 16.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.46B | 3.52B | 2.45B | 4.14B | 5.90B |
| Operating Cash Flow | 0.00 | -2.37B | 3.54B | 2.56B | 4.18B | 6.11B |
| Investing Cash Flow | 0.00 | -46.47M | -16.50M | -117.80M | 462.77M | -106.08M |
| Financing Cash Flow | 0.00 | 1.21B | -5.13B | 1.78B | -3.99B | -5.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥2.49T | 12.40 | 11.12% | 4.17% | 9.27% | -11.27% | |
64 Neutral | ¥8.47B | 15.87 | ― | 3.58% | 10.75% | 117.39% | |
64 Neutral | ¥1.03T | 9.73 | 11.28% | 3.21% | 10.17% | -19.40% | |
62 Neutral | ¥12.92B | 58.56 | ― | 3.44% | ― | ― | |
62 Neutral | ¥17.41B | 12.21 | ― | 3.75% | 19.17% | -42.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥116.78B | 47.87 | ― | 5.49% | -16.48% | -77.63% |